Sign Up to like & get
recommendations!
0
Published in 2023 at "Hematological oncology"
DOI: 10.1002/hon.3126
Abstract: Ibrutinib-associated atrial fibrillation (IRAF) emerged among the adverse events of major interests in ibrutinib-treated patients as real-world studies showed a higher incidence compared to clinical trials. We prospectively analysed predictors of IRAF in 43 single-center…
read more here.
Keywords:
fibrillation year;
ibrutinib associated;
predictors ibrutinib;
associated atrial ... See more keywords